{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:18:30Z","timestamp":1791299910925,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Trish MS Research Foundation (Australia)"},{"name":"Star Scientific Foundation (Australia)"},{"DOI":"10.13039\/501100002337","name":"Petre Foundation (Australia)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (Australia)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.autrev.2015.12.004","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T04:54:07Z","timestamp":1450414447000},"page":"307-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":254,"title":["Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination"],"prefix":"10.1016","volume":"15","author":[{"given":"Sudarshini","family":"Ramanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Brilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.12.004_bb0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","article-title":"Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphodiesterase in the CNS of adult rats","volume":"52","author":"Brunner","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2015.12.004_bb0010","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.139.12.4016","article-title":"A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease","volume":"139","author":"Schluesener","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0015","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1073\/pnas.90.17.7990","article-title":"Myelin\/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex","volume":"90","author":"Pham-Dinh","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.12.004_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jnr.490330123","article-title":"Myelin\/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily","volume":"33","author":"Gardinier","year":"1992","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.autrev.2015.12.004_bb0025","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1046\/j.1471-4159.1994.63062353.x","article-title":"Characterization and expression of the cDNA coding for the human myelin\/oligodendrocyte glycoprotein","volume":"63","author":"Pham-Dinh","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2015.12.004_bb0030","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein","volume":"130","author":"Linington","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0040","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(77)91603-8","article-title":"Immunoglobulin-containing cells in multiple-sclerosis plaques","volume":"2","author":"Esiri","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2015.12.004_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2990.1980.tb00199.x","article-title":"Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system","volume":"6","author":"Esiri","year":"1980","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.410100205","article-title":"Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown","volume":"10","author":"Prineas","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.410430409","article-title":"Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination","volume":"43","author":"Storch","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0065","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.12.004_bb0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0165-5728(84)90064-X","article-title":"A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody","volume":"6","author":"Linnington","year":"1984","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-5728(87)90031-2","article-title":"Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin\/oligodendrocyte glycoprotein (MOG)","volume":"17","author":"Linington","year":"1987","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.157.2.919","article-title":"Analysis of the fine B cell specificity during the chronic\/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35\u201355","volume":"157","author":"Ichikawa","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-5728(95)00124-7","article-title":"The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat","volume":"63","author":"Adelmann","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0090","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0095","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.4049\/jimmunol.154.10.5536","article-title":"Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis","volume":"154","author":"Johns","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0100","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/intimm\/8.11.1667","article-title":"Antibody response in lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides","volume":"8","author":"Ichikawa","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0105","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4049\/jimmunol.181.2.1255","article-title":"Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents","volume":"181","author":"Breithaupt","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0165-5728(00)00462-8","article-title":"The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls","volume":"114","author":"Haase","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0115","doi-asserted-by":"crossref","first-page":"8207","DOI":"10.1073\/pnas.122092499","article-title":"Molecular characterization of antibody specificities against myelin\/oligodendrocyte glycoprotein in autoimmune demyelination","volume":"99","author":"von Budingen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.12.004_bb0120","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1073\/pnas.1133443100","article-title":"Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein","volume":"100","author":"Breithaupt","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.12.004_bb0125","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/eji.200425050","article-title":"Frontline: epitope recognition on the myelin\/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination","volume":"34","author":"von Budingen","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(99)00010-7","article-title":"Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG)","volume":"97","author":"Brehm","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0135","doi-asserted-by":"crossref","first-page":"17206","DOI":"10.1074\/jbc.M111.304246","article-title":"Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity","volume":"287","author":"de Graaf","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2015.12.004_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1440-1789.2010.01131.x","article-title":"Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE","volume":"31","author":"Ohtani","year":"2011","journal-title":"Neuropathology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0145","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/eji.200425291","article-title":"Commentary: sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)-specific autoantibody repertoire","volume":"34","author":"Mathey","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0150","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0504979102","article-title":"Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology","volume":"102","author":"Marta","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.12.004_bb0155","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.1300019","article-title":"The encephalitogenic, human myelin oligodendrocyte glycoprotein-induced antibody repertoire is directed toward multiple epitopes in C57BL\/6-immunized mice","volume":"191","author":"Bansal","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1742-2094-8-161","article-title":"Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis","volume":"8","author":"Menge","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"Pt 11","key":"10.1016\/j.autrev.2015.12.004_bb0165","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/122.11.2047","article-title":"Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study","volume":"122","author":"Reindl","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.12.004_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archneur.56.3.311","article-title":"Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis","volume":"56","author":"Karni","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(03)00066-2","article-title":"Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients","volume":"211","author":"Markovic","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2015.12.004_bb0180","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1212\/01.WNL.0000147259.34163.33","article-title":"Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis","volume":"63","author":"Gaertner","year":"2004","journal-title":"Neurology"},{"issue":"Pt 11","key":"10.1016\/j.autrev.2015.12.004_bb0185","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/brain\/122.11.2089","article-title":"Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein","volume":"122","author":"Lindert","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.12.004_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/135245850100700503","article-title":"Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis","volume":"7","author":"Egg","year":"2001","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00415-006-0299-4","article-title":"Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF","volume":"254","author":"Kuhle","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","article-title":"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event","volume":"349","author":"Berger","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp.2005.077784","article-title":"Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event","volume":"77","author":"Rauer","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2015.12.004_bb0210","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458507077622","article-title":"Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS","volume":"13","author":"Tomassini","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2007.00872.x","article-title":"Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort","volume":"116","author":"Greeve","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2015.12.004_bb0220","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4049\/jimmunol.175.3.1974","article-title":"Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein","volume":"175","author":"O'Connor","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458506072189","article-title":"Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations","volume":"13","author":"Pittock","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-5728(02)00271-0","article-title":"Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis","volume":"131","author":"Lutterotti","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0235","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/01.WNL.0000127615.15768.AE","article-title":"Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects","volume":"62","author":"Lampasona","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0240","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1191\/1352458505ms1187sr","article-title":"Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis","volume":"11","author":"Lim","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0250","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMc062467","article-title":"Antimyelin antibodies with no progression to multiple sclerosis","volume":"356","author":"Pelayo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0255","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/01.wnl.0000316195.52001.e1","article-title":"Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults","volume":"71","author":"Wang","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0260","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2006.01.012","article-title":"Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: influence of relapses and immunomodulatory treatments","volume":"174","author":"Khalil","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0265","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/eji.200737249","article-title":"Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA","volume":"37","author":"Menge","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0270","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1212\/01.WNL.0000130069.55343.06","article-title":"Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis","volume":"62","author":"Reder","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0275","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/nyas.12764","article-title":"Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry","volume":"1351","author":"Sinmaz","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2015.12.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0285","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000012","article-title":"Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton","volume":"1","author":"Dale","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.autrev.2015.12.004_bb0290","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0295","article-title":"Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis","author":"Ramanathan","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O'Connor","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0305","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.0801888","article-title":"Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis","volume":"183","author":"McLaughlin","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0310","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ana.21916","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease","volume":"66","author":"Brilot","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458510389220","article-title":"Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children","volume":"17","author":"Lalive","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0325","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Probstel","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0330","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1073\/pnas.0510672103","article-title":"Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis","volume":"103","author":"Lalive","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.12.004_bb0335","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","article-title":"Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.12.004_bb0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2015.12.004_bb0345","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/1352458510376406","article-title":"Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis","volume":"16","author":"Chan","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0350","article-title":"Clinical and MRI phenotype of children with MOG antibodies","author":"Fernandez-Carbonell","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0355","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrneurol.2011.45","article-title":"White matter disease: roles of anti-MOG antibodies in demyelinating diseases","volume":"7","author":"Olsson","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2015.12.004_bb0365","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0375","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2015.12.004_bb0380","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0385","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0395","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.12.004_bb0400","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0405","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0410","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0415","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2377-13-104","article-title":"Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis","volume":"13","author":"Saini","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0420","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2015.12.004_bb0425","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.12.004_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.03.008","article-title":"Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis","volume":"261","author":"Wu","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0435","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-immunol-020711-075041","article-title":"Brain-reactive antibodies and disease","volume":"31","author":"Diamond","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0440","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0445","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1212\/WNL.0b013e318296e917","article-title":"Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity","volume":"80","author":"Marignier","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0450","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0455","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-1004521","article-title":"Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions","volume":"38","author":"Ishikawa","year":"2007","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.autrev.2015.12.004_bb0460","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e3181dc1a7f","article-title":"NMDA receptor encephalitis mimicking seronegative neuromyelitis optica","volume":"74","author":"Kruer","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0465","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature","volume":"114","author":"Jarius","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2015.12.004_bb0470","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0475","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","article-title":"Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis","volume":"69","author":"Rostasy","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0480","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1352458512470310","article-title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica","volume":"19","author":"Rostasy","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0485","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.autrev.2015.12.004_bb0490","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0495","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"Hoftberger","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0500","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","article-title":"Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype","volume":"12","author":"Probstel","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2015.12.004_bb0505","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","author":"Ramanathan","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0510","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications","author":"Cobo-Calvo","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0515","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0520","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jnnp-2013-306411","article-title":"Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort","volume":"85","author":"Hacohen","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2015.12.004_bb0525","article-title":"MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study","author":"Akaishi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.autrev.2015.12.004_bb0530","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jocn.2013.07.017","article-title":"Autoimmune encephalitis: recent updates and emerging challenges","volume":"21","author":"Ramanathan","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.autrev.2015.12.004_bb0535","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0540","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1352458511431973","article-title":"Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder","volume":"18","author":"Min","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2015.12.004_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0550","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/brain\/awh260","article-title":"Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats","volume":"127","author":"Sakuma","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2015.12.004_bb0555","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"Bettelli","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0560","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/08916934.2013.796938","article-title":"Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process","volume":"46","author":"Soares","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2015.12.004_bb0565","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1167\/iovs.04-0554","article-title":"Myelin\/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL\/6 mouse","volume":"45","author":"Shao","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2015.12.004_bb0570","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1172\/JCI28330","article-title":"Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell\/B cell cooperation","volume":"116","author":"Krishnamoorthy","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2015.12.004_bb0575","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","article-title":"Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a devic-like disease in mice","volume":"116","author":"Bettelli","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2015.12.004_bb0580","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0b013e31823c9b6c","article-title":"Relationship between NMO-antibody and anti-MOG antibody in optic neuritis","volume":"32","author":"Kezuka","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0585","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2014.03.001","article-title":"Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system","volume":"270","author":"Tanaka","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0590","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2014.3602","article-title":"Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor alpha1 subunit in patients with isolated optic neuritis","volume":"72","author":"Martinez-Hernandez","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0595","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0600","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0605","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000002","article-title":"NMDA receptor antibodies associated with distinct white matter syndromes","volume":"1","author":"Hacohen","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0610","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.1301296","article-title":"Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases","volume":"191","author":"Mayer","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0615","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.164","article-title":"Histopathology and clinical course of MOG-antibody-associated encephalomyelitis","volume":"2","author":"Spadaro","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0620","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1471-4159.1990.tb04173.x","article-title":"Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin\/oligodendrocyte glycoprotein","volume":"55","author":"Kerlero de Rosbo","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2015.12.004_bb0625","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"143","author":"Piddlesden","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0630","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2051-5960-2-35","article-title":"Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain","volume":"2","author":"Saadoun","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.autrev.2015.12.004_bb0635","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.autrev.2015.12.004_bb0640","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.autrev.2015.12.004_bb0645","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0650","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181e04096","article-title":"Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases","volume":"74","author":"Selter","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2015.12.004_bb0655","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0660","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2015.12.004_bb0665","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.4049\/jimmunol.1400700","article-title":"Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood\u2013brain barrier","volume":"193","author":"Winger","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.12.004_bb0670","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1172\/JCI71544","article-title":"Immune cell trafficking from the brain maintains CNS immune tolerance","volume":"124","author":"Mohammad","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2015.12.004_bb0675","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008879","article-title":"B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes","volume":"6","author":"Stern","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2015.12.004_bb0680","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000060","article-title":"MOG antibody-associated diseases","volume":"2","author":"Reindl","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2015.12.004_bb0685","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.autrev.2015.01.017","article-title":"Autoantibodies 2015: from diagnostic biomarkers toward prediction, prognosis and prevention","volume":"14","author":"Damoiseaux","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.12.004_bb0690","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.12.004_bb0695","doi-asserted-by":"crossref","first-page":"673503","DOI":"10.1155\/2015\/673503","article-title":"Decreased frequency of circulating myelin oligodendrocyte glycoprotein B lymphocytes in patients with relapsing-remitting multiple sclerosis","volume":"2015","author":"Elong Ngono","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2015.12.004_bb0700","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.braindev.2015.02.006","article-title":"Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies","volume":"37","author":"Hino-Fukuyo","year":"2015","journal-title":"Brain and Development"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721500261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721500261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T06:05:03Z","timestamp":1692165903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721500261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":140,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S156899721500261X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.12.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}